← Back to Clinical Trials
Recruiting NCT06792045

NCT06792045 Prediction of Tongue Base Obstruction During Sleep

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06792045
Status Recruiting
Phase
Sponsor Université Catholique de Louvain
Condition Obstructive Sleep Disordered Breathing
Study Type OBSERVATIONAL
Enrollment 48 participants
Start Date 2025-08-22
Primary Completion 2027-10

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
Physiotherapist assessmentENT assessmentDrug-Induced Sleep Endoscopy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 48 participants in total. It began in 2025-08-22 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study investigates the hypothesis that, in children, tongue motor functions can predict both the anatomical site and the degree of upper airway obstruction contributing to obstructive sleep-disordered breathing.

Eligibility Criteria

Inclusion Criteria: * Age between 6 and 17 years old * Medical diagnosis of obstructive sleep-disordered breathing requiring surgical removal of tonsils (partial or total) and/or adenoids * Positive Pediatric Sleep Questionnaire (8 or more positive responses) * Eligibility for surgical intervention Exclusion Criteria: * Neurological, cardiac, or respiratory comorbidity other than obstructive sleep-disordered breathing * Previous surgery of the upper airway or oral cavity * History of or current head or neck cancer * Cranial, upper airway, or oral cavity malformation * Contraindication to performing endoscopy

Contact & Investigator

Central Contact

William Poncin, Pr, Dr.

✉ william.poncin@uclouvain.be

📞 +32470592032

Frequently Asked Questions

Who can join the NCT06792045 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Obstructive Sleep Disordered Breathing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06792045 currently recruiting?

Yes, NCT06792045 is actively recruiting participants. Contact the research team at william.poncin@uclouvain.be for enrollment information.

Where is the NCT06792045 trial being conducted?

This trial is being conducted at Brussels, Belgium.

Who is sponsoring the NCT06792045 clinical trial?

NCT06792045 is sponsored by Université Catholique de Louvain. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology